- a strong leadership team,
- proven product-market fit, and
- a clear go-to-market strategy.
February 3, 2020
This article was originally published on Inc Magazine and discusses how as an entrepreneur, your startup needs more than just cash and your investors should help. It features Mighty Capital alongside leading VC firms like Redpoint Ventures and Andreessen Horowitz.Read More
July 12, 2019
Deal brings single-cell genomics to China and accelerates Mission Bio’s mission to predict and prevent cancer relapse on a global scaleRead More
June 27, 2019
An effective branding strategy requires seeing your entire constituent universe and transmitting a constant, cohesive and comprehensive values message.Read More
May 21, 2019
Cancer is smart. Yes, you read that right.
The disease isn’t intelligent in the traditional sense — but cancer cells are adaptable, ‘learning’ from their environment and constantly evolving to improve survival. While targeted therapy can be effective at first, this evolution means that treatment resistance and disease progression remain a challenge.
To effectively combat cancer — to both detect it sooner and develop the most impactful, dynamic therapies — we need to be able to understand it. This means tracking the progression of each and every cancerous cell.Read More
May 7, 2019
How top marketers are winning against digital-only disruptors by bringing location to the cloud.Read More
Listen to the Product Guru Bruce Cleveland discuss the importance of Bridging The Traction Gap for startups and investors alike:
- Building the framework for success factors that turn startups into sustainable businesses
- What it takes for companies with promising tech to become industry powerhouses
- The difference between seeking out investors and having investors come to you
April 24, 2019
Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) and its partners, including Fabric Genomics, have today published in Science Translational Medicine a new study documenting the process to diagnose rare genetic diseases in record time. This new method speeds answers to physicians and allows increased use of genome sequencing as a first-line diagnostic test for critically ill babies.Read More